Defining the correlation between immune-checkpoint inhibitors-related adverse events and survival outcomes: A systematic review and meta-analysis

被引：0
|
作者：
Abdihamid, O. [1 ]
机构：
[1] Cent South Univ, CSU, Xiangya Sch Med, Oncol Dept, New Campus, Changsha, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.10.098
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
80P
引用
收藏
页码：S1406 / S1407
页数：2
相关论文
共 50 条
  • [41] The correlation between immune-related adverse events and efficacy of immune checkpoint inhibitors
    Fukushima, Taito
    Kobayashi, Satoshi
    Ueno, Makoto
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (09) : 949 - 958
  • [42] Cutaneous Adverse Events and Cancer Survival Prognosis With Immune Checkpoint Inhibitor Treatment A Systematic Review and Meta-Analysis
    Du, Yaxin
    Wu, Wenjie
    Chen, Mei
    Dong, Zhengbang
    Wang, Fei
    JAMA DERMATOLOGY, 2023, 159 (10) : 1093 - 1101
  • [43] Cutaneous adverse events associated with immune checkpoint blockade: A systematic review and meta-analysis
    Han, Yiqun
    Wang, Jiayu
    Xu, Binghe
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 163
  • [44] Incidence of Cutaneous Immune-Related Adverse Events and Outcomes in Immune Checkpoint Inhibitor-Containing Regimens: A Systematic Review and Meta-Analysis
    Curkovic, Nina B.
    Bai, Kun
    Ye, Fei
    Johnson, Douglas B.
    CANCERS, 2024, 16 (02)
  • [45] Impact of Center Volume on Cardiopulmonary and Mortality Outcomes after Immune-Checkpoint Inhibitors for Cancer: A Systematic Review and Meta-Analysis
    Rahouma, Mohamed
    Mynard, Nathan
    Baudo, Massimo
    Khairallah, Sherif
    Al-Thani, Shaikha
    Dabsha, Anas
    Shmushkevich, Shon
    Shoeib, Osama
    Hossny, Mohamed
    Eldeeb, Elsayed
    Aziz, Hala
    Abdelkarim, Naglaa
    Gaudino, Mario
    Mohamed, Abdelrahman
    Girardi, Leonard
    Zhang, Jun
    Mutti, Luciano
    CANCERS, 2024, 16 (06)
  • [46] Immune-Related Adverse Events (irAE) in Cancer Immune Checkpoint Inhibitors (ICI) and Survival Outcomes Correlation: To Rechallenge or Not?
    Albandar, Heidar J.
    Fuqua, Jacob
    Albandar, Jasim M.
    Safi, Salahuddin
    Merrill, Samuel A.
    Ma, Patrick C.
    CANCERS, 2021, 13 (05) : 1 - 15
  • [47] Cardiovascular adverse events associated with immune checkpoint inhibitors: a meta-analysis
    Li, Xi
    Li, Dan
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [48] Obesity and immune-checkpoint inhibitors in advanced melanoma: A meta-analysis of survival outcomes from clinical studies
    Roccuzzo, Gabriele
    Moirano, Giovenale
    Fava, Paolo
    Maule, Milena
    Ribero, Simone
    Quaglino, Pietro
    SEMINARS IN CANCER BIOLOGY, 2023, 91 : 27 - 34
  • [49] Gastrointestinal treatment-related adverse events of combined immune checkpoint inhibitors: a meta-analysis
    Karna, Rahul
    S Deliwala, Smit
    Ramgopal, Balasubramanian
    Asawa, Palash
    Mishra, Rahul
    P Mohan, Babu
    Jayakrishnan, Thejus
    Grover, Dheera
    Kalra, Tanisha
    Bhalla, Jaideep
    Saraswati, Ushasi
    Gangwani, Manesh K.
    Dhawan, Manish
    Adler, Douglas G.
    IMMUNOTHERAPY, 2023, 15 (10) : 773 - 786
  • [50] USE OF IMMUNE CHECKPOINT INHIBITORS AND RISK OF IMMUNE-RELATED ADVERSE EVENTS AMONG PATIENTS WITH ADVANCED MELANOMA: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Chang, C. Y.
    Park, H.
    Lo-Ciganic, W.
    VALUE IN HEALTH, 2019, 22 : S89 - S89
12345